CanSense is a company that specializes in cancer diagnostics. They offer a simple blood test that can detect bowel cancer early. The test is non-invasive and reduces colonoscopies. Bowel (colorectal) cancer is the second most common cancer globally.
However, they are a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
Location: United Kingdom, England, Wales
Employees: 1-10
Total raised: $1.78M
Founded date: 2018
Founders name: Cerys Jenkins
Founders Related Locations: United Kingdom; United Kingdom, Scotland, Glasgow
Funding Rounds 1
Date | Series | Amount | Investors |
08.03.2023 | Seed | $1.78M | Mercia Ass... |
Persons 5
Date | First Name | Last Name | Title | Location | |||
- | Adam | Bryant | Chief Exec... | linkedin.c... | - | A*********... | - |
- | Peter | Dunstan | - | linkedin.c... | - | p*********... | - |
- | Dean | Webster | - | linkedin.c... | - | d*********... | - |
- | Justin | John | - | linkedin.c... | - | j*********... | - |
- | Cerys | Jenkins | Co-Founder... | linkedin.c... | - | - | - |
Mentions in press and media 4
Date | Title | Description | Source |
09.01.2024 | GP finger-prick blood test could transform bowel cancer diag... | Welsh patients are playing a major role in the way that bowel cancer is diagnosed, thanks to a leadi... | einpresswi... |
09.03.2023 | Start-up raises £1.5m for blood test to detect early-stage b... | CanSense – a Swansea company which has developed a blood test that aims to save lives by diagnosing ... | mercia.co.... |
08.03.2023 | CanSense Raises £1.5M in Funding | CanSense, a Swansea, UK-based developer of blood test to detect early-stage bowel cancer, raised £1.... | finsmes.co... |
- | CanSense | “CanSense – Innovation in cancer diagnostics” | fastfounde... |